Catalyst
Slingshot members are tracking this event:
Astellas (ALPMY) and Ironwood (IRWD) Expect to Launch Linzess in Japan for the Treatment of Adults with IBS-C in the First Half of 2017
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Catalyst Date
Occurred on:
May 08, 2017
Occurred Source:
http://news.ironwoodpharma.com/phoenix.zhtml?c=228069&p=irol-newsArticle&ID=2270730
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Linzess, Ibs-c, Commercial Launch, Irritable Bowel Syndrome With Constipation
